Oxidative stress and metabolic parameters in hypertensive patients with/without diabetes mellitus in cardiovascular risk evaluation

1. Bernabé-Ortiz A, Carrillo-Larco RM, Gilman RH, Checkley W, Smeeth L, Miranda JJ, CRONICAS Cohort Study Group. Impact of urbanisation and altitude on the incidence of, and risk factors for, hypertension. Heart. 2017 Jun;103(11):827-3310.1136/heartjnl-2016-310347552998028115473 Search in Google Scholar

2. Roumie CL, Hung AM, Russell GB, Basile J, Kreider KE, Nord J, et al. Blood pressure control and the association with diabetes mellitus incidence: results from SPRINT randomized trial. Hypertension. 2020 Feb;75(2):331-810.1161/HYPERTENSIONAHA.118.12572701514731865790 Search in Google Scholar

3. Shaikh A. A practical approach to hypertension management in diabetes. Diabetes Ther. 2017 Oct;8(5):981-910.1007/s13300-017-0310-3563056428929319 Search in Google Scholar

4. Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018 May;34(5):575-8410.1016/j.cjca.2017.12.005595355129459239 Search in Google Scholar

5. Carey RM, Wright Jr JT, Taler SJ, Whelton PK. Guideline-driven management of hypertension: an evidence-based update. Circ Res. 2021 Apr;128(7):827-4610.1161/CIRCRESAHA.121.318083803480133793326 Search in Google Scholar

6. Del Pinto R, Ferri C. Inflammation-accelerated senescence and the cardiovascular system: mechanisms and perspectives. Int J Mol Sci. 2018 Dec;19(12):370110.3390/ijms19123701632136730469478 Search in Google Scholar

7. Mahajan N, Arora P, Sandhir R. Perturbed biochemical pathways and associated oxidative stress lead to vascular dysfunctions in diabetic retinopathy. Oxid Med Cell Longev. 2019 Mar;2019:1-1610.1155/2019/8458472643138030962865 Search in Google Scholar

8. Tilinca MC, Barabas-Hajdu EC, Ferencz GT, Nemes-Nagy E. Involvement of inflammatory cytokines in obesity and its complications. R Rom Med Lab. 2018;26(3):359-7110.2478/rrlm-2018-0019 Search in Google Scholar

9. Vona R, Gambardella L, Cittadini C, Straface E, Pietra-forte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid Med Cell Longev. 2019 Oct;2019:1-1910.1155/2019/8267234652582331191805 Search in Google Scholar

10. Prakash D. Target organ damage in newly detected hypertensive patients. J Family Med Prim Care. 2019 Jun;8(6):2042-4610.4103/jfmpc.jfmpc_231_19661823131334177 Search in Google Scholar

11. Wali U, Hussain MM, Wali N, Nadeem A, Majeed F. Comparison of serum levels of Cystatin-C and traditional renal biomarkers for the early detection of pre-hypertensive nephropathy. J Pak Med Assoc. 2019 Mar 1;69(3):313-19 Search in Google Scholar

12. Elsayed MS, El Badawy A, Omar R, Mohamed A. Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2019 Jan;13(1):374-8110.1016/j.dsx.2018.08.01730641728 Search in Google Scholar

13. Khalil H. Diabetes microvascular complications - A clinical update. Diabetes Metab Syndr Clin Res Rev. 2017;11:S133-910.1016/j.dsx.2016.12.02227993541 Search in Google Scholar

14. Greaney JL, Saunders EF, Santhanam L, Alexander LM. Oxidative stress contributes to microvascular endothelial dysfunction in men and women with major depressive disorder. Circ Res. 2019;124(4):564-7410.1161/CIRCRESAHA.118.313764637580030582458 Search in Google Scholar

15. Mirmiran P, Hosseini-Esfahani F, Esfandiar Z, Hossein-pour-Niazi S, Azizi F. Associations between dietary antioxidant intakes and cardiovascular disease. Sci Rep. 2022 Jan;12(1):1-1110.1038/s41598-022-05632-x879539935087166 Search in Google Scholar

16. Ruiz-Castell M, Le Coroller G, Landrier JF, Kerkour D, Weber B, Fagherazzi G, et al. Micronutrients and Markers of Oxidative Stress and Inflammation Related to Cardiometabolic Health: Results from the EHESLUX Study. Nutrients. 2021 Jan;13(5):1-1310.3390/nu13010005782200933374992 Search in Google Scholar

17. Gould RL, Pazdro R. Impact of supplementary amino acids, micronutrients, and overall diet on glutathione homeostasis. Nutrients. 2019 May;11(5):1051-5610.3390/nu11051056656616631083508 Search in Google Scholar

18. Ho E, Galougahi KK, Liu CC, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox biology. 2013 Jan;1(1):483-9110.1016/j.redox.2013.07.006383006324251116 Search in Google Scholar

19. Bigagli E, Lodovici M. Circulating oxidative stress biomarkers in clinical studies on type 2 diabetes and its complications. Oxid Med Cell Longev. 2019 May;2019:1-1710.1155/2019/5953685653585931214280 Search in Google Scholar

20. Fogarasi E, Croitoru MD, Fülöp I, Nemes-Nagy E, Tripon RG, Simon-Szabo Z, et al. Malondialdehyde levels can be measured in serum and saliva by using a fast HPLC method with visible detection. R Rom Med Lab Vol. 2016;24(3):319-326 Search in Google Scholar

21. Artha IM, Bhargah A, Dharmawan NK, Pande UW, Triyana KA, Mahariski PA, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus. Vasc Health Risk Manag. 2019;15:149-15710.2147/VHRM.S209830656018331239693 Search in Google Scholar

22. Yiğitbaşı T, Baskın Y, Akgöl E, Çalıbaşı Koçal G, Ellidokuz H. Association of ischemia-modified albumin with oxidative stress status and insulin resistance in obese patients. R Rom Med Lab. 2017. 25(3):255-6310.1515/rrlm-2017-0020 Search in Google Scholar

23. Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, et al. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2017 Nov;19(11):1570-810.1111/dom.1297628432733 Search in Google Scholar

24. Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population. BMC neurology. 2019 Dec;19(1):1-810.1186/s12883-019-1373-8660443331266453 Search in Google Scholar

25. Song Y, Choi JE, Kwon YJ, Chang HJ, Kim JO, Park DH, et al. Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia. J Transl Med. 2021 Dec;19(1):1-110.1186/s12967-021-02751-3790588333632238 Search in Google Scholar

26. Brudașcă I, Cucuianu M. Abnormal lipid metabolism in metabolic syndrome: an epigenetic perspective. R Rom Med Lab. 2016 Jun;24(2):153-6010.1515/rrlm-2016-0025 Search in Google Scholar

27. Epingeac ME, Gaman MA, Diaconu CC, Gaman AM. Crosstalk between Oxidative Stress and Inflammation in Obesity. Rev. Chim. 2020;71:228-32 Search in Google Scholar

28. Pouvreau C, Dayre A, Butkowski EG, De Jong B, Jelinek HF. Inflammation and oxidative stress markers in diabetes and hypertension. J Inflamm Res. 2018;11:61-6810.2147/JIR.S148911582284429497324 Search in Google Scholar

29. Wang L, Ahn YJ, Asmis R. Sexual dimorphism in glutathione metabolism and glutathione-dependent responses. Redox Biology. 2020 Apr;31:101410:1-910.1016/j.redox.2019.101410721249131883838 Search in Google Scholar

30. Williams CR, Mistry M, Cheriyan AM, Williams JM, Naraine MK, Ellis CL, et al. Zinc deficiency induces hypertension by promoting renal Na+ reabsorption. Am J Physiol Ren Physiol. 2019 Apr;316(4):F646-5310.1152/ajprenal.00487.2018648302830649891 Search in Google Scholar

31. Choi S, Liu X, Pan Z. Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacol Sin. 2018 Jul;39(7):1120-3210.1038/aps.2018.25628939629926844 Search in Google Scholar

32. Pawluk H, Pawluk R, Robaczewska J, Kędziora-Kornatowska K, Kędziora J. Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension. Redox Report. 2017 Nov;22(6):542-610.1080/13510002.2017.1372072890062028873049 Search in Google Scholar

33. Găman MA, Epîngeac ME, Diaconu CC, Găman AM. Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with anthropo-metric and laboratory parameters. World J Diabetes. 2020 May;11(5):19310.4239/wjd.v11.i5.193724348432477455 Search in Google Scholar

34. Casoinic F, Sampelean D, Buzoianu AD, Hancu N, Baston D. Serum levels of oxidative stress markers in patients with type 2 diabetes mellitus and non-alcoholic steatohepatitis. Rom J Intern Med. 2016 Dec;54(4):228-3610.1515/rjim-2016-003528002036 Search in Google Scholar

35. Ahmad KA, Yuan Yuan D, Nawaz W, Ze H, Zhuo CX, Talal B, et al. Antioxidant therapy for management of oxidative stress induced hypertension. Free Radic Res. 2017 Apr;51(4):428-3810.1080/10715762.2017.132220528427291 Search in Google Scholar

36. Keti DB, Muhtaroglu S. Reliability of Friedewald formula in patients with type 2 diabetes mellitus and its relation to lipid profile in diabetes regulation. Rev Romana Med Lab. 2021;29(2):179-187 Search in Google Scholar